Progressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: The VALUE trial

By Kjeldsen Sverre   Mcinnes Gordon   Mancia Giuseppe   Hua Tsushung   Julius Stevo   Weber Michael   Coca Antonio   Girerd Xavier   Jamerson Kenneth   Larochelle Pierre   Macdonald Thomas   Schmieder Roland   Anthony Schork M.   Viskoper Reuven   Widimsky Jiri   Zanchetti Alberto  

Blood Pressure, Vol. 17, Iss. 3, 2008-01 ,pp. : 170-177

Informa Healthcare

Access to resources Recommend Favorite

Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance

By Hu Yaomin  

Acta Diabetologica, Vol. 47, Iss. 3, 2010-09 ,pp. : 231-236

Springer Publishing Company

Access to resources Recommend Favorite

Progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screening programme in general practice: the ADDITION Study, Denmark

By Rasmussen S.   Glümer C.   Sandbaek A.   Lauritzen T.   Borch-Johnsen K.  

Diabetologia, Vol. 50, Iss. 2, 2007-02 ,pp. : 293-297

Springer Publishing Company

Access to resources Recommend Favorite

Temporal changes in prevalence of diabetes and impaired glucose tolerance associated with lifestyle transition occurring in the rural population in India

By Ramachandran A.   Snehalatha C.   Baskar A.   Mary S.   Sathish Kumar C.   Selvam S.   Catherine S.   Vijay V.  

Diabetologia, Vol. 47, Iss. 5, 2004-05 ,pp. : 860-865

Springer Publishing Company

Access to resources Recommend Favorite

The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) Trial of Cardiovascular Events in Hypertension. Rationale and Design

By MANN JESSICA   JULIUS STEVO  

Blood Pressure, Vol. 7, Iss. 3, 1998-08 ,pp. : 176-183

Informa Healthcare

Access to resources Recommend Favorite